Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 91-100 of 148 for

Edit search filters
  1. A Study to Evaluate the Safety and Effectiveness of Ustekinumab as Initial or Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis

    Jacksonville, FL

  2. Ultrasound Evaluation of Crohn's Disease

    Rochester, MN

  3. A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease

    Rochester, MN

  4. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

    Rochester, MN

  5. A Study to Evaluate Intra-arterial Delivery of Mesenchymal Stem Cells for Luminal Ulcerative Colitis

    Rochester, MN

  6. AMG 181 in Subjects with Moderate to Severe Crohn's Disease

    Rochester, MN

  7. A Study to Evaluate Safety and Effectiveness of SHP647 as Induction Therapy in Participants with Moderate-to- Severe Crohn's Disease

    La Crosse, WI

  8. Vedolizumab IV in Pediatric Participants With Ulcerative Colitis or Crohn's Disease

    Rochester, MN

  9. Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

    Rochester, MN

  10. A Study of the Safety and Effectiveness of GS-5745 in Adults with Moderately to Severely Active Ulcerative Colitis

    Rochester, MN

.

Mayo Clinic Footer